Tazarotene | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Tazarotene

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 8 USDMF, 2 EU WC, 8 NDC API, 10 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

FINISHED DOSAGE FORMULATIONS

31 FDF Dossiers, 18 FDA Orange Book, 2 Europe, 2 Canada, 2 South Africa, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, FOAM;TOPICAL - 0.1%, CREAM;TOPICAL - 0.05%, CREAM;TOPICAL - 0.1%

RELATED EXCIPIENT COMPANIES

5 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 Actylis, 6 BASF, 1 BioSpectra, 1 Clariant, 2 Corel Pharma Chem, 1 Finar, 2 Gangwal Chemicals, 2 Lubrizol Life Science Health, 2 Microlex e.U, 2 Nanjing Bold Chemical, 4 Seppic

EXCIPIENTS BY APPLICATIONS

16 Topical, 11 Solubilizers, 6 Parenteral, 6 Thickeners and Stabilizers, 5 Emulsifying Agents, 4 Surfactant & Foaming Agents, 2 Coating Systems & Additives, 1 Film Formers & Plasticizers, 1 Granulation, 1 Lubricants & Glidants, 1 Direct Compression, 1 Fillers, Diluents & Binders, 1 Rheology Modifiers, 1 Taste Masking, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 22 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 3 Regulatory FDF Prices, 3 Annual Reports

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

16 US Patents, 1 US Exclusivities, 6 Health Canada Patents

$ Xls

Filters

Filters

FILTER :

filter Company Name Reset all filters

1 All

01 1PADAGIS ISRAEL

filter Product Reset all filters

filter Exclusivity Expiration Date Reset all filters

filter Exclusivity Code Reset all filters

Product Main Page

01

PADAGIS ISRAEL

Immuno-Oncology 360

Not Confirmed

Contact us
to update this info